Colorectal polyps
Conditions
Interventions
Conventional-EMR Group:Conventional-EMR
Anchored-EMR Group:Anchored-EMR
Sponsors
Meizhou People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Colonoscopy confirms the presence of polyps with a diameter >=10 mm, and pathological biopsy (if performed preoperatively) or postoperative pathology confirms colorectal polyps (adenomatous polyps, hyperplastic polyps, inflammatory polyps, etc.), with the polyp morphology being sessile (Paris classification types 0-IIa, 0-IIb, or 0-Is). The patient has an American Society of Anesthesiologists (ASA) physical status classification of I-III and is able to tolerate endoscopic surgery. Age 18-75 years, with no gender restrictions. The patient and their family understand the study content and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.The polyp has undergone cancerous transformation (pathology indicates intramucosal carcinoma or invasive carcinoma) or is suspected of malignancy (such as ulceration on the polyp surface, firm texture, or unclear margins). Presence of severe dysfunction in vital organs such as the heart, liver, or kidneys (e.g., heart failure NYHA class =IV, decompensated cirrhosis, chronic kidney failure stage 5). Coagulation abnormalities (prothrombin time >14 seconds, activated partial thromboplastin time >40 seconds, platelet count <100×10?/L) or long-term use of anticoagulants or antiplatelet drugs (warfarin, rivaroxaban, aspirin, clopidogrel) with discontinuation <7 days. Poor bowel preparation quality (Boston Bowel Preparation Scale score <6), unable to clearly expose the polyp. Comorbid conditions such as intestinal stenosis, intestinal obstruction, perforation, or acute intestinal infection. Psychiatric disorders, cognitive impairment, or communication difficulties that hinder cooperation with surgery and follow-up. History of colorectal surgery (excluding polypectomy) or inflammatory bowel disease (ulcerative colitis, Crohn's disease).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| En Bloc Resection Rate;Complete Polyp Resection Rate;R0 Resection Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative Blood Loss;Postoperative Complication Rate;Piecemeal Resection Rate;Postoperative Polyp Recurrence Rate; | — |
Countries
China
Contacts
Public ContactZhong Xiongping
Meizhou People's Hospital
Outcome results
None listed